Concepts (88)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Blood Transfusion, Intrauterine | 4 | 1991 | 4 | 0.280 |
Why?
|
| Infant, Newborn | 10 | 2007 | 2614 | 0.140 |
Why?
|
| Rh Isoimmunization | 3 | 1991 | 8 | 0.130 |
Why?
|
| Neonatal Abstinence Syndrome | 1 | 1996 | 6 | 0.130 |
Why?
|
| Ethics, Medical | 1 | 1996 | 312 | 0.100 |
Why?
|
| Hydrops Fetalis | 1 | 1991 | 17 | 0.090 |
Why?
|
| Zidovudine | 1 | 1990 | 16 | 0.090 |
Why?
|
| Embryonic and Fetal Development | 1 | 1990 | 71 | 0.080 |
Why?
|
| Erythropoiesis | 1 | 1990 | 53 | 0.080 |
Why?
|
| Hemolysis | 1 | 1990 | 63 | 0.080 |
Why?
|
| Fetal Growth Retardation | 1 | 1990 | 72 | 0.080 |
Why?
|
| Conjunctivitis, Viral | 1 | 1988 | 1 | 0.070 |
Why?
|
| Endocarditis | 1 | 1988 | 25 | 0.070 |
Why?
|
| Haemophilus Infections | 1 | 1988 | 9 | 0.070 |
Why?
|
| Gestational Age | 4 | 1998 | 343 | 0.070 |
Why?
|
| Immunoglobulins, Intravenous | 1 | 2007 | 70 | 0.060 |
Why?
|
| Infant, Premature, Diseases | 1 | 2007 | 85 | 0.060 |
Why?
|
| Cross Infection | 1 | 2007 | 159 | 0.060 |
Why?
|
| Immunologic Factors | 1 | 2007 | 179 | 0.060 |
Why?
|
| Staphylococcal Infections | 1 | 2007 | 289 | 0.050 |
Why?
|
| Blood Transfusion | 2 | 1997 | 182 | 0.050 |
Why?
|
| Sepsis | 1 | 2007 | 391 | 0.050 |
Why?
|
| Pregnancy | 4 | 1997 | 3240 | 0.050 |
Why?
|
| Anemia | 3 | 1997 | 137 | 0.050 |
Why?
|
| HIV Infections | 1 | 1990 | 974 | 0.040 |
Why?
|
| Fetal Diseases | 2 | 1991 | 81 | 0.040 |
Why?
|
| Birth Weight | 2 | 1990 | 152 | 0.040 |
Why?
|
| Lymphocyte Subsets | 1 | 1998 | 69 | 0.040 |
Why?
|
| Purpura | 1 | 1997 | 13 | 0.030 |
Why?
|
| Porphyrins | 1 | 1997 | 37 | 0.030 |
Why?
|
| Phototherapy | 1 | 1997 | 36 | 0.030 |
Why?
|
| Mother-Child Relations | 1 | 1996 | 31 | 0.030 |
Why?
|
| Disclosure | 1 | 1996 | 111 | 0.030 |
Why?
|
| Skin Diseases | 1 | 1997 | 176 | 0.030 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 1996 | 176 | 0.030 |
Why?
|
| Pregnancy Complications | 1 | 1996 | 356 | 0.030 |
Why?
|
| Humans | 11 | 2007 | 96093 | 0.020 |
Why?
|
| Female | 7 | 2007 | 50030 | 0.020 |
Why?
|
| Substance-Related Disorders | 1 | 1996 | 451 | 0.020 |
Why?
|
| Hyperinsulinism | 1 | 1991 | 48 | 0.020 |
Why?
|
| HIV Antigens | 1 | 1990 | 4 | 0.020 |
Why?
|
| HIV Core Protein p24 | 1 | 1990 | 6 | 0.020 |
Why?
|
| Gene Products, gag | 1 | 1990 | 12 | 0.020 |
Why?
|
| Viral Core Proteins | 1 | 1990 | 28 | 0.020 |
Why?
|
| Anemia, Neonatal | 1 | 1990 | 5 | 0.020 |
Why?
|
| Blood Cell Count | 1 | 1990 | 79 | 0.020 |
Why?
|
| Hematocrit | 1 | 1990 | 69 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 1990 | 363 | 0.020 |
Why?
|
| Hemoglobins | 1 | 1990 | 196 | 0.020 |
Why?
|
| Ultrasonography, Prenatal | 1 | 1990 | 155 | 0.020 |
Why?
|
| Pregnancy Outcome | 1 | 1991 | 273 | 0.020 |
Why?
|
| Risk Assessment | 1 | 1996 | 2480 | 0.020 |
Why?
|
| Erythromycin | 1 | 1988 | 10 | 0.020 |
Why?
|
| Gentamicins | 1 | 1988 | 21 | 0.020 |
Why?
|
| Ampicillin | 1 | 1988 | 16 | 0.020 |
Why?
|
| Haemophilus influenzae | 1 | 1988 | 17 | 0.020 |
Why?
|
| Infant, Very Low Birth Weight | 1 | 2007 | 53 | 0.020 |
Why?
|
| Longitudinal Studies | 1 | 1990 | 1175 | 0.020 |
Why?
|
| Survival Rate | 1 | 1991 | 1985 | 0.020 |
Why?
|
| Age of Onset | 1 | 2007 | 344 | 0.020 |
Why?
|
| Drug Therapy, Combination | 1 | 1988 | 813 | 0.020 |
Why?
|
| Infant, Premature | 1 | 2007 | 308 | 0.010 |
Why?
|
| Length of Stay | 1 | 2007 | 833 | 0.010 |
Why?
|
| Comorbidity | 1 | 2007 | 1011 | 0.010 |
Why?
|
| Double-Blind Method | 1 | 2007 | 1791 | 0.010 |
Why?
|
| Male | 4 | 2007 | 45870 | 0.010 |
Why?
|
| Prognosis | 1 | 1988 | 4029 | 0.010 |
Why?
|
| Time Factors | 1 | 2007 | 5585 | 0.010 |
Why?
|
| Cell Separation | 1 | 1998 | 205 | 0.010 |
Why?
|
| Anemia, Hemolytic, Congenital | 1 | 1997 | 1 | 0.010 |
Why?
|
| Coproporphyrins | 1 | 1997 | 1 | 0.010 |
Why?
|
| Exchange Transfusion, Whole Blood | 1 | 1997 | 18 | 0.010 |
Why?
|
| Hyperbilirubinemia | 1 | 1997 | 21 | 0.010 |
Why?
|
| Protoporphyrins | 1 | 1997 | 19 | 0.010 |
Why?
|
| Fetofetal Transfusion | 1 | 1997 | 8 | 0.010 |
Why?
|
| Erythroblastosis, Fetal | 1 | 1997 | 12 | 0.010 |
Why?
|
| Reference Values | 1 | 1998 | 675 | 0.010 |
Why?
|
| Necrosis | 1 | 1997 | 210 | 0.010 |
Why?
|
| Flow Cytometry | 1 | 1998 | 727 | 0.010 |
Why?
|
| Keratinocytes | 1 | 1997 | 146 | 0.010 |
Why?
|
| Radiation Dosage | 1 | 1997 | 236 | 0.010 |
Why?
|
| Biopsy | 1 | 1997 | 1220 | 0.010 |
Why?
|
| Glutathione | 1 | 1991 | 107 | 0.010 |
Why?
|
| Fetal Blood | 1 | 1991 | 96 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 1997 | 3927 | 0.010 |
Why?
|
| Blood Glucose | 1 | 1991 | 873 | 0.000 |
Why?
|
| Insulin | 1 | 1991 | 1190 | 0.000 |
Why?
|
| Adult | 1 | 1998 | 28716 | 0.000 |
Why?
|